These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 8965135
1. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia. Tadamura E, Tamaki N, Okazawa H, Fujibayashi Y, Kudoh T, Yonekura Y, Magata Y, Nohara R, Sasayama S, Konishi J. J Nucl Med; 1996 May; 37(5):729-35. PubMed ID: 8965135 [Abstract] [Full Text] [Related]
2. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. Herrero P, Hartman JJ, Green MA, Anderson CJ, Welch MJ, Markham J, Bergmann SR. J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759 [Abstract] [Full Text] [Related]
3. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography. Herrero P, Markham J, Weinheimer CJ, Anderson CJ, Welch MJ, Green MA, Bergmann SR. Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005 [Abstract] [Full Text] [Related]
5. Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM. Beanlands RS, Muzik O, Hutchins GD, Wolfe ER, Schwaiger M. J Nucl Cardiol; 1994 Jan; 1(3):225-35. PubMed ID: 9420705 [Abstract] [Full Text] [Related]
6. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET. Okazawa H, Yonekura Y, Fujibayashi Y, Nishizawa S, Magata Y, Ishizu K, Tanaka F, Tsuchida T, Tamaki N, Konishi J. J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968 [Abstract] [Full Text] [Related]
7. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM. Haynes NG, Lacy JL, Nayak N, Martin CS, Dai D, Mathias CJ, Green MA. J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116 [Abstract] [Full Text] [Related]
8. The kinetics of copper-62-PTSM in the normal human heart. Beanlands RS, Muzik O, Mintun M, Mangner T, Lee K, Petry N, Hutchins GD, Schwaiger M. J Nucl Med; 1992 May; 33(5):684-90. PubMed ID: 1569476 [Abstract] [Full Text] [Related]
10. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM. Wallhaus TR, Lacy J, Whang J, Green MA, Nickles RJ, Stone CK. J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589 [Abstract] [Full Text] [Related]
11. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. Green MA, Mathias CJ, Welch MJ, McGuire AH, Perry D, Fernandez-Rubio F, Perlmutter JS, Raichle ME, Bergmann SR. J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398 [Abstract] [Full Text] [Related]
12. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. Green MA, Klippenstein DL, Tennison JR. J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785 [Abstract] [Full Text] [Related]
13. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM. Mathias CJ, Welch MJ, Raichle ME, Mintun MA, Lich LL, McGuire AH, Zinn KR, John EK, Green MA. J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007 [Abstract] [Full Text] [Related]
14. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM. Matsumoto K, Fujibayashi Y, Yonekura Y, Wada K, Takemura Y, Konishi J, Yokoyama A. Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613 [Abstract] [Full Text] [Related]
15. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. Mathias CJ, Bergmann SR, Green MA. J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593 [Abstract] [Full Text] [Related]
16. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. J Nucl Med; 1989 Nov; 30(11):1843-7. PubMed ID: 2809749 [Abstract] [Full Text] [Related]
17. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography. Shelton ME, Green MA, Mathias CJ, Welch MJ, Bergmann SR. Circulation; 1990 Sep; 82(3):990-7. PubMed ID: 2394015 [Abstract] [Full Text] [Related]
18. Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects. Okazawa H, Fujibayashi Y, Yonekura Y, Tamaki N, Nishizawa S, Magata Y, Ishizu K, Tsuchida T, Sadato N, Konishi J. Ann Nucl Med; 1995 May; 9(2):81-7. PubMed ID: 7662494 [Abstract] [Full Text] [Related]
19. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, Michel C, Vanoverschelde JL. J Nucl Med; 1998 Oct; 39(10):1655-62. PubMed ID: 9776263 [Abstract] [Full Text] [Related]
20. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Flower MA, Zweit J, Hall AD, Burke D, Davies MM, Dworkin MJ, Young HE, Mundy J, Ott RJ, McCready VR, Carnochan P, Allen-Mersh TG. Eur J Nucl Med; 2001 Jan; 28(1):99-103. PubMed ID: 11202458 [Abstract] [Full Text] [Related] Page: [Next] [New Search]